Molecular characterization of acute myeloid leukemia patients who relapse more than 3 years after diagnosis: an exome sequencing study of 31 patients

Documenti analoghi

• Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia
  di: Meggendorfer, Manja, et al.
  Pubblicazione: (2015)
• NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse
  di: Höllein, Alexander, et al.
  Pubblicazione: (2018)
• Molecular characterization of AML with RUNX1-RUNX1T1 at diagnosis and relapse reveals net loss of co-mutations
  di: Alexander Höllein, et al.
  Pubblicazione: (2019-02-01)
• Molecular characterization of AML with RUNX1-RUNX1T1 at diagnosis and relapse reveals net loss of co-mutations
  di: Höllein, Alexander, et al.
  Pubblicazione: (2019)
• Detection and characterization of homozygosity of mutated CALR by copy neutral loss of heterozygosity in myeloproliferative neoplasms among cases with high CALR mutation loads or with progressive disease
  di: Stengel, Anna, et al.
  Pubblicazione: (2019)